![Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-13-03841/article_deploy/html/images/cancers-13-03841-ag.png?1628043076)
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
![IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients](https://www.mdpi.com/ijms/ijms-21-07295/article_deploy/html/images/ijms-21-07295-g001.png)
IJMS | Free Full-Text | Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients
![Expression of cellular activation/exhaustion markers on HLA-DR+ and... | Download Scientific Diagram Expression of cellular activation/exhaustion markers on HLA-DR+ and... | Download Scientific Diagram](https://www.researchgate.net/publication/336060043/figure/fig2/AS:807361455341570@1569501379334/Expression-of-cellular-activation-exhaustion-markers-on-HLA-DR-and-HLA-DR-CD4-memory.png)
Expression of cellular activation/exhaustion markers on HLA-DR+ and... | Download Scientific Diagram
![Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation](https://www.frontiersin.org/files/Articles/680480/fimmu-12-680480-HTML/image_m/fimmu-12-680480-g001.jpg)
Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
![Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/patient_ed/human_leukocyte_antigen_hla_typing_and_stem_cell_collection_information_for_donors-129784/hla_markers-en.png)
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
![Deregulation of HLA-I in cancer and its central importance for immunotherapy | Journal for ImmunoTherapy of Cancer Deregulation of HLA-I in cancer and its central importance for immunotherapy | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/8/e002899/F3.large.jpg)
Deregulation of HLA-I in cancer and its central importance for immunotherapy | Journal for ImmunoTherapy of Cancer
![HLA‐DR‐expressing NK cells: Effective killers suspected for antigen presentation - Erokhina - 2021 - Journal of Leukocyte Biology - Wiley Online Library HLA‐DR‐expressing NK cells: Effective killers suspected for antigen presentation - Erokhina - 2021 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/a4567932-9781-4e5a-9708-78e397c44f64/jlb10651-gra-0001-m.jpg?trick=1697402946020)
HLA‐DR‐expressing NK cells: Effective killers suspected for antigen presentation - Erokhina - 2021 - Journal of Leukocyte Biology - Wiley Online Library
![Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram](https://www.researchgate.net/publication/49742362/figure/fig1/AS:202968864432134@1425402956239/Expression-of-activation-CD38-and-HLA-DR-and-senescence-CD57-and-CD28-markers-on-CD4.png)
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
![Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy](https://www.cell.com/cms/asset/3d2fc5eb-7a47-44ac-bfe9-4614c58afa16/fx1.jpg)
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
![Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection - ScienceDirect Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721009724-fx1.jpg)
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection - ScienceDirect
![Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research](https://www.ahajournals.org/cms/asset/aaeb2292-737e-43af-a29d-9c6d7556154d/circresaha.122.321116.fig09.jpg)
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
![Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04bdee40-bc61-4d23-b36c-13cd8220d591/imm12936-fig-0001-m.jpg)